News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
13,089 Results
Type
Article (733)
Company Profile (19)
Press Release (12337)
Section
Business (4481)
Career Advice (16)
Deals (651)
Drug Delivery (2)
Drug Development (2330)
Employer Resources (2)
FDA (205)
Job Trends (272)
News (7210)
Policy (379)
Tag
Academia (37)
Adcomms (3)
Allergies (5)
Alliances (1210)
ALS (1)
Alzheimer's disease (10)
Antibody-drug conjugate (ADC) (9)
Approvals (202)
Artificial intelligence (4)
Bankruptcy (4)
Best Places to Work (218)
BIOSECURE Act (5)
Biosimilars (1)
Biotechnology (15)
Bladder cancer (1)
Cancer (58)
Cardiovascular disease (6)
Career advice (10)
CAR-T (9)
Cell therapy (30)
Clinical research (1786)
Collaboration (31)
Compensation (17)
COVID-19 (102)
CRISPR (4)
C-suite (11)
Cystic fibrosis (1)
Data (51)
Diabetes (3)
Diagnostics (31)
Drug discovery (2)
Earnings (1414)
Editorial (1)
Employer resources (2)
Events (2411)
Executive appointments (36)
FDA (232)
Funding (29)
Gene editing (8)
Gene therapy (19)
GLP-1 (17)
Government (44)
Guidances (1)
Healthcare (385)
Immunology and inflammation (4)
Infectious disease (103)
Inflammatory bowel disease (7)
Intellectual property (4)
Interviews (3)
IPO (359)
Job creations (62)
Job search strategy (10)
Kidney cancer (1)
Labor market (2)
Layoffs (13)
Legal (65)
Liver cancer (1)
Lung cancer (6)
Lymphoma (11)
Machine learning (1)
Management (1)
Manufacturing (9)
MASH (1)
Medical device (63)
Medtech (63)
Mergers & acquisitions (305)
Metabolic disorders (7)
Neurodegenerative disease (5)
Neuroscience (19)
NextGen: Class of 2025 (139)
Non-profit (19)
Now hiring (1)
Obesity (3)
Opinion (1)
Ovarian cancer (1)
Pain (6)
Pancreatic cancer (1)
Parkinson's disease (3)
Patents (10)
Patient recruitment (3)
People (1680)
Phase I (807)
Phase II (871)
Phase III (526)
Pipeline (32)
Policy (8)
Postmarket research (25)
Preclinical (271)
Press Release (1)
Prostate cancer (2)
Radiopharmaceuticals (2)
Rare diseases (7)
Real estate (112)
Recruiting (1)
Regulatory (318)
Reports (2)
Research institute (62)
Resumes & cover letters (3)
RSV (1)
Schizophrenia (3)
Series A (9)
Series B (2)
Service/supplier (1)
Special edition (1)
Spinal muscular atrophy (1)
Sponsored (2)
Startups (104)
Supply chain (2)
Vaccines (11)
Weight loss (1)
Date
Today (6)
Last 7 days (27)
Last 30 days (70)
Last 365 days (941)
2025 (297)
2024 (1027)
2023 (1262)
2022 (1597)
2021 (1624)
2020 (1243)
2019 (738)
2018 (540)
2017 (663)
2016 (546)
2015 (592)
2014 (399)
2013 (343)
2012 (292)
2011 (296)
2010 (310)
Location
Africa (14)
Asia (1066)
Australia (89)
California (280)
Canada (77)
China (20)
Colorado (2)
Connecticut (8)
Delaware (5)
Europe (1264)
Florida (18)
Idaho (1)
Illinois (5)
India (1)
Indiana (1)
Japan (3)
Maryland (47)
Massachusetts (123)
Michigan (2)
Minnesota (4)
New Jersey (46)
New Mexico (1)
New York (23)
North Carolina (14)
Northern California (103)
Oklahoma (1)
Pennsylvania (47)
South America (9)
Southern California (103)
Texas (21)
United States (650)
Utah (2)
Washington D.C. (2)
Washington State (9)
Wisconsin (1)
13,089 Results for "asterias biotherapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Antibody-drug conjugate (ADC)
Roche Ups ADC Bet With $1B in Biobucks for Oxford BioTherapeutics
Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for undisclosed cancer targets.
March 19, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Interius BioTherapeutics to Present at Upcoming Scientific Meetings
April 17, 2025
·
2 min read
Press Releases
Adolore BioTherapeutics to Present at Festival of Biologics USA 2025
April 24, 2025
·
3 min read
Press Releases
Tavo Biotherapeutics Announces Appointment of Seasoned Executives to Key Posts
April 30, 2025
·
3 min read
Press Releases
Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses
April 23, 2025
·
8 min read
Press Releases
Stealth BioTherapeutics to Present New Bevemipretide Data at ARVO Annual Meeting
April 24, 2025
·
5 min read
Press Releases
Stealth BioTherapeutics Announces Delay in FDA Action Date for Barth Syndrome Application
April 29, 2025
·
3 min read
Press Releases
Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer
April 8, 2025
·
7 min read
Press Releases
Artiva Biotherapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
April 1, 2025
·
3 min read
Press Releases
FORE Biotherapeutics to Present Plixorafenib Abstract at the 2025 American Society of Clinical Oncology Annual Meeting
April 30, 2025
·
1 min read
1 of 1,309
Next
